Sofinnova Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-414,207
| Closed | -$34.6M | – | 69 |
|
|
2023
Q4 | $34.6M | Sell |
414,207
-645,957
| -61% | -$53.9M | 1.93% | 13 |
|
|
2023
Q3 | $31.2M | Buy |
1,060,164
+216,936
| +26% | +$6.39M | 1.97% | 18 |
|
|
2023
Q2 | $27.5M | Buy |
843,228
+489,432
| +138% | +$16M | 1.8% | 17 |
|
|
2023
Q1 | $12.5M | Sell |
353,796
-155,134
| -30% | -$5.46M | 0.8% | 29 |
|
|
2022
Q4 | $23.3M | Buy |
508,930
+188,208
| +59% | +$8.62M | 1.38% | 18 |
|
|
2022
Q3 | $15.5M | Sell |
320,722
-58
| -0% | -$2.81K | 0.9% | 20 |
|
|
2022
Q2 | $12.6M | Buy |
320,780
+257,836
| +410% | +$10.1M | 1.05% | 22 |
|
|
2022
Q1 | $2.32M | Sell |
62,944
-401,422
| -86% | -$14.8M | 0.18% | 45 |
|
|
2021
Q4 | $21.2M | Buy |
464,366
+37,734
| +9% | +$1.72M | 1.24% | 19 |
|
|
2021
Q3 | $15.2M | Sell |
426,632
-54,691
| -11% | -$1.95M | 0.9% | 21 |
|
|
2021
Q2 | $9.53M | Buy |
481,323
+91,603
| +24% | +$1.81M | 0.55% | 38 |
|
|
2021
Q1 | $9.07M | Sell |
389,720
-118,674
| -23% | -$2.76M | 0.55% | 38 |
|
|
2020
Q4 | $10.6M | Buy |
508,394
+159,098
| +46% | +$3.31M | 0.63% | 29 |
|
|
2020
Q3 | $7.56M | Buy |
349,296
+189,079
| +118% | +$4.09M | 0.56% | 28 |
|
|
2020
Q2 | $3.78M | Buy |
+160,217
| New | +$3.78M | 0.24% | 50 |
|
|
2019
Q4 | – | Sell |
-210,992
| Closed | -$2.4M | – | 62 |
|
|
2019
Q3 | $2.4M | Buy |
+210,992
| New | +$2.4M | 0.22% | 51 |
|